Good pick up, a significant mismatch to the current SP, providing the reported figures are correct.
Done a quick comparison of NPV's with DYL and CXO, the MEK SP has a significant amount of catching up to do.
This all hinges on the figures quoted being accurate.
One would expect them to be, so why is the SP being held down.
No doubt there's more at play here than is being reported.
Look forward to seeing the SP reflect the NPV value quoted!
- Forums
- ASX - By Stock
- MEK
- Ann: September 2023 Quarterly Activities Report
Ann: September 2023 Quarterly Activities Report, page-3
Featured News
Add MEK (ASX) to my watchlist
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $41.98M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $19.11K | 565K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16009 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 599542 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16009 | 0.033 |
2 | 185537 | 0.032 |
2 | 230940 | 0.031 |
2 | 899009 | 0.030 |
1 | 251000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 599542 | 5 |
0.035 | 1862757 | 6 |
0.036 | 800000 | 1 |
0.037 | 500070 | 2 |
0.038 | 183510 | 3 |
Last trade - 13.28pm 03/07/2024 (20 minute delay) ? |
Featured News
MEK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online